Alector reports inducement grants as permitted by the nasdaq listing rules

South san francisco, calif., march 01, 2022 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that the compensation committee of alector's board of directors granted marc grasso, m.d., the company's newly-hired chief financial officer, an inducement equity grant on march 1, 2022, consisting of inducement stock options to purchase an aggregate of 450,000 shares of the company's common stock. these inducement stock options are subject to the terms of alector's 2022 inducement equity incentive plan and related forms of agreements and were granted as inducements material to new employees entering into employment with alector in accordance with nasdaq listing rule 5635(c)(4).
ALEC Ratings Summary
ALEC Quant Ranking